Form 8-K
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported)        October 4, 2002
 
 
Targeted Genetics Corporation
(Exact name of registrant as specified in charter)
 
 
Washington
 
0-23930
 
91-1549568
(State or other jurisdiction
 
(Commission
 
(IRS Employer
of incorporation)
 
File Number)
 
Identification No.)
 
 
1100 Olive Way, Suite 100, Seattle, Washington
  
98101
 
(Address of principal executive offices)
  
(Zip Code
)
 
 
Registrant’s telephone number, including area code        (206) 623-7612
 
 
Not Applicable
(Former name or former address, if changed since last report)


 
Item 5.    Other Events.
 
On October 4, 2002, Targeted Genetics Corporation announced the preliminary data from its Phase II Cystic Fibrosis clinical trials. The text of the press release is set forth in Exhibit 99.1 attached to this release and incorporated herein by this reference. On October 8, 2002, Targeted Genetics Corporation announced the receipt of collaborative funding from Biogen, Inc. through the exercise of a put right. The text of the press release is set forth in Exhibit 99.2 attached to this release and incorporated herein by this reference.
 
Item 7.    Exhibits.
 
(a)    Financial statements of business acquired.
 
Not applicable.
 
(b)    Pro forma financial information.
 
Not applicable.
 
(c)    Exhibits.
 
Exhibit No.

  
Description

99.1
  
Press Release dated October 4, 2002
99.2
  
Press Release dated October 8, 2002


 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
       
TARGETED GENETICS CORPORATION
           
By:
 
/s/    Todd E. Simpson        

Date:  October 8, 2002
         
Vice President, Finance and Administration and
Chief Financial Officer, Secretary and Treasurer
(Principal Financial and Accounting Officer)


 
EXHIBIT INDEX
 
Exhibit No.

  
Description

99.1
  
Press Release dated October 4, 2002
99.2
  
Press Release dated October 8, 2002